Actor Yoo Ah-in appears for questioning over alleged drug use | Inquirer Entertainment

Actor Yoo Ah-in appears for questioning over alleged drug use

/ 10:58 AM March 27, 2023

Actor Yoo Ah-in enters the Seoul Metropolitan Police Agency building in Seoul on Monday. (Yonhap via The Korea Herald / ANN)

Actor Yoo Ah-in enters the Seoul Metropolitan Police Agency building in Seoul on Monday. (Yonhap via The Korea Herald / ANN)

Korean Actor Yoo Ah-in appeared before police for questioning Monday over allegations of illegal drug use.

The 37-year-old actor, whose real name is Uhm Hong-sik, entered the Seoul Metropolitan Police Agency building in Seoul without responding to any questions from reporters.

Article continues after this advertisement

Yoo has been under investigation after the Ministry of Food and Drug Safety said his prescription purchases of propofol for nonmedical purposes have been too frequent since 2021. It is a powerful sleep-inducing drug commonly used in surgeries.

Police earlier sent his hair and urine samples to the National Forensic Service for tests, and Yoo additionally tested positive for marijuana, cocaine and ketamine. —Yonhap 

RELATED STORIES:

Korean actor Yoo Ah-in dropped from Netflix series ‘Hellbound’

Yoo Ah-in also tests positive for cocaine, ketamine — reports

Korean actor Yoo Ah-in tests positive for marijuana use

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Drug Addiction, Propofol, Yoo Ah-in

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.